SCOPUS 정보 검색 플랫폼

Drug Discovery Today

Volumn 14, Issue 21-22, 2009, Pages 1003-1005

Open Innovation: share or die...

(1) Talaga, Patrice a

a UCB PHARMA (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COMBINATORIAL CHEMISTRY; COMMERCIAL PHENOMENA; COST BENEFIT ANALYSIS; DECISION MAKING; DRUG INDUSTRY; ECONOMIC ASPECT; EDITORIAL; MOTIVATION; PATENT; PHARMACY; PRODUCTIVITY; REIMBURSEMENT; VALIDATION PROCESS;

COOPERATIVE BEHAVIOR; DRUG DISCOVERY; DRUG INDUSTRY; RESEARCH;

EID: 70350416088 PISSN: 13596446 EISSN: None Source Type: Journal
DOI: 10.1016/j.drudis.2009.09.001 Document Type: Editorial

Times cited : (19)

References (11)

1
- 70350389976
- Deloitte report highlight Pharma executive's concerns
- Deloitte report highlight Pharma executive's concerns. Future Med. Chem. 1 (2009) 17
- (2009) Future Med. Chem. , vol.1 , pp. 17

2
- 70350355270
- Recent drug approvals from the US FDA and EMEA: what the future holds
- Pevarello P. Recent drug approvals from the US FDA and EMEA: what the future holds. Future Med. Chem. 1 (2009) 35-48
- (2009) Future Med. Chem. , vol.1 , pp. 35-48
- Pevarello, P.¹

3
- 67349156630
- The road ahead for large Pharma: long term science and innovation
- Lundberg J.M., et al. The road ahead for large Pharma: long term science and innovation. Drug Discov. Today 14 (2009) 439-441
- (2009) Drug Discov. Today , vol.14 , pp. 439-441
- Lundberg, J.M.¹

4
- 70350402521
- Le Montreux Palace, Switzerland, June15-16
- 10th Annual Drug Discovery Leaders Summit. Le Montreux Palace, Switzerland, June15-16 (2009)
- (2009) 10th Annual Drug Discovery Leaders Summit

5
- 66749150437
- Open innovation networks between academia and industry: an imperative for breakthrough therapies
- Melese T., et al. Open innovation networks between academia and industry: an imperative for breakthrough therapies. Nat. Med. 15 (2009) 502-507
- (2009) Nat. Med. , vol.15 , pp. 502-507
- Melese, T.¹

6
- 0038210300
- Harvard Business School Press, Boston, MA
- Chesbrough H. Open Innovation the New Imperative for Creating and Profiting from Technology (2003), Harvard Business School Press, Boston, MA
- (2003) Open Innovation the New Imperative for Creating and Profiting from Technology
- Chesbrough, H.¹

7
- 58149141541
- Drug discovery: new models for industry-academic partnerships
- Tralau-Stewart C.J., et al. Drug discovery: new models for industry-academic partnerships. Drug Discov. Today 14 (2008) 95-101
- (2008) Drug Discov. Today , vol.14 , pp. 95-101
- Tralau-Stewart, C.J.¹

8
- 33748324666
- Can open-source R&D reinvigorate drug research?
- Munos B. Can open-source R&D reinvigorate drug research?. Nat. Rev. Drug Discov. 5 (2006) 723-729
- (2006) Nat. Rev. Drug Discov. , vol.5 , pp. 723-729
- Munos, B.¹

9
- 52049085009
- Drug discovery in the era of Facebook - new tools for scientific networking
- Bailey D.S., et al. Drug discovery in the era of Facebook - new tools for scientific networking. Drug Discov. Today 13 (2008) 863-868
- (2008) Drug Discov. Today , vol.13 , pp. 863-868
- Bailey, D.S.¹

10
- 65249148491
- Creating successful innovation partnerships
- Traiter H., et al. Creating successful innovation partnerships. Foodtechnology (2009). pp. 23-35 www.ift.org
- (2009) Foodtechnology
- Traiter, H.¹

11
- 65549170931
- Harnessing open innovation. Nat. Rev. Drug. Discov. 8 (2009) 344-345
- (2009) Nat. Rev. Drug. Discov. , vol.8 , pp. 344-345
- Harnessing open innovation¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.